|Day Low/High||3.90 / 4.00|
|52 Wk Low/High||2.45 / 4.65|
- CTI BioPharma reincorporated in State of Delaware, delisted from Borsa Italiana MTA Exchange
TheStreet's biotech columnist offers his own report card on biotech stocks.
A look back at the year's worth of Adam Feuerstein's biotech tweets.
Gilead Sciences is nearing the completion of two phase III studies of the Jak inhibitor momelotinib in myelofibrosis, a disease affecting bone marrow.
Stocks with insider trader activity include LPNT, PATK and CTIC
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of CTI BioPharma Corp.
Lundin Law PC announces a class action lawsuit has been filed against CTI BioPharma Corp.
Law Offices of Howard G. Smith reminds investors of the upcoming April 11, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased CTI BioPharma Corp.
Stocks with insider trader activity include SPTN, FL and CTIC
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.